Overview of Dr. Saeed
An associate member at Moffitt cancer center specializing in the treatment of Hodgkins, T cell and B cell lymphoma.
Office
12902 Magnolia Dr.
Tampa, FL 33612Fax+1 813-745-3875
Education & Training
- University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 2013 - 2016
- University of Kentucky College of MedicineResidency, Internal Medicine, 2010 - 2013
- University of Baghdad College of MedicineClass of 2006
Certifications & Licensure
- FL State Medical License 2019 - 2025
- KY State Medical License 2013 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- AACR/ASCO Clinical trial workshop in Vail,CO AACR/ASCO, 2016
- Letter of Achievement UK hematology oncology fellowship program, 2015-2016
- Clinical trial boot camp Markey Cancer Center, 2014
- Join now to see all
Clinical Trials
- Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma Start of enrollment: 2018 Dec 19
Publications & Presentations
PubMed
- Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell Lymphoma.Yumeng Zhang, Ashley Rose, Sushmita Khadka, Biwei Cao, Jennifer Eatrides
Transplantation and Cellular Therapy. 2024-09-01 - compatibility of admixture solutions of 5-fluorouracil and khapzory (disodium levofolinate) in a single infusion bag.Hayder Saeed
Journal of Oncology Pharmacy Practice. 2024-07-25 - The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.Rahul S Bhansali, Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li
Blood Advances. 2024-07-09
Journal Articles
- Age Adjusted Hematopoietic Stem Cell Transplant Comorbidity Index Predicts Survival in a T-cell Depleted Cohort☆Swati Yalamanchi, Hayder Saeed, Dianna Howard, Gerhard C Hildebrandt, Roger Herzig, Gregory Monohan, ScienceDirect
Abstracts/Posters
- Impact of Interim FDG-PET (iPET) in the Outcomes of Patients with Aggressive B-Cell Lymphomas Receiving DA-EPOCH-RHayder Saeed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Use of Lenalidomide Plus Rituximab in TP53-Mutated Mantle Cell Lymphoma (MCL) Outside of Clinic Trial: The Moffitt ExperienceHayder Saeed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Authored Content
- Unleashing the Spark: My Top #ASH23 Posts That Ignited EngagementDecember 2023
- Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?December 2022
- An Update on T Cell Lymphoma from SOHO 2021September 2021
Press Mentions
- CME Information - May 2018January 28th, 2018
Professional Memberships
- Fellow
- Member
Other Languages
- Arabic
External Links
- Pubmed Profilehttp://goo.gl/3BmVhl
- Twitter https://twitter.com/HayderSaeed_MD
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: